Implantation of Hypoxia-Induced Mesenchymal Stem Cell Advances Therapeutic Angiogenesis

<div>Schedule of the study and hindlimb ischemic model. (a) Protocol schedule for the in vivo disease model, mesenchymal stem cell (MSC) implantations, follow-up, and acquisition of samples. (b) Hindlimb ischemic model and phosphate-buffered saline (PBS)/MSC/hypoxia-induced MSC (hi-MSC) injection sites (stars).</div>

Stem Cells International

fig1

Figure 1

Figure 1: Implantation of Hypoxia-Induced Mesenchymal Stem Cell Advances Therapeutic Angiogenesis 